01—Abstract
Summary
Summary of the 8-K filed January 8, 2024. Cited figures are marked; the original filing is the authoritative source.
On January 8, 2024, TransUnion disclosed under Item 4.02 that its Audit Committee concluded, on January 6, 2024, that the unaudited consolidated financial statements for the three and nine months ended September 30, 2023 (included in the Form 10-Q filed October 24, 2023) were materially misstated and should no longer be relied upon.
Related earnings releases, investor presentations and similar communications describing those statements are also no longer to be relied upon. The error was an overstatement of approximately $80 milliona in non-cash goodwill impairment, tied to the United Kingdom reporting unit. The filing attributes it primarily to a computational error in the manual translation of the U.S. Dollar equivalent of revenue in the base-year forecast used in the reporting unit's fair value valuation model.
The company identified a material weakness in internal control over financial reporting as of September 30, 2023, and concluded that its disclosure controls and procedures were not effective at the reasonable assurance level as of that date. TransUnion plans to file a Form 10-Q/A as soon as practicable, with restated unaudited financial statements for the periods referenced and related amendments, including details on the material weakness and its remediation plan. Management and the Audit Committee have discussed these matters with PricewaterhouseCoopers LLP.
The filing states there was no impact on cash flows from operating activities, since goodwill impairment is a non-cash adjustment. It also states that compliance with debt covenants and the performance metrics used in calculating executive compensation are not affected. Under Item 7.01, the company states the error had no impact on its non-GAAP measures, including Consolidated Adjusted EBITDA, Adjusted Net Income, Adjusted Diluted Earnings per Share and Leverage Ratio, for the three and nine months ended September 30, 2023.
02—Key points
Key Highlights
- Non-reliance: The Audit Committee concluded on January 6, 2024 that the Q3 2023 interim financial statements in the October 24, 2023 Form 10-Q were materially misstated and should no longer be relied upon.
- Error size and source: The error overstated non-cash goodwill impairment by approximately $80 million, associated with the United Kingdom reporting unit.
- Root cause: A computational error in the manual translation of the U.S. Dollar equivalent of base-year forecast revenue used in the valuation model.
- Controls: A material weakness in internal control over financial reporting was identified as of September 30, 2023, and disclosure controls were concluded to be not effective at the reasonable assurance level.
- Restatement timing: A Form 10-Q/A with restated unaudited financial statements for the three and nine months ended September 30, 2023 is planned as soon as practicable.
- No cash or covenant impact: The filing states there was no effect on cash flows from operating activities or on debt covenant compliance, and executive compensation performance metrics are not impacted.
- Non-GAAP measures unaffected: The error had no impact on Consolidated Adjusted EBITDA, Adjusted Net Income, Adjusted Diluted EPS, Leverage Ratio and other non-GAAP measures for the Q3 2023 periods.
03—Questions
Frequently Asked Questions
What financial statements are affected by this filing?
The unaudited consolidated financial statements as of and for the three and nine months ended September 30, 2023, included in the Form 10-Q filed October 24, 2023, are no longer to be relied upon. Related earnings releases, investor presentations and similar communications describing them are also affected.
How large is the error and where did it occur?
The error overstated the non-cash goodwill impairment by approximately $80 million. The overstatement was associated with the company's United Kingdom reporting unit.
Does this error affect cash flow or debt covenant compliance?
According to the filing, there was no impact on cash flows from operating activities, because goodwill impairment is a non-cash adjustment. The company's compliance with its debt covenants is also not impacted.
What happens next, and what is the company doing about the control issue?
TransUnion plans to file a Form 10-Q/A as soon as practicable with restated unaudited financial statements for the three and nine months ended September 30, 2023, along with amendments to MD&A, controls and procedures, risk factors and exhibits. The company will provide further details on the material weakness and its remediation plan in that amendment. Management and the Audit Committee have discussed these matters with PricewaterhouseCoopers LLP.
04—Continue